))
This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM
Manage episode 446210798 series 3232962
Contenu fourni par Adam Sarhan. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Adam Sarhan ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM
Guest: Geert Kersten CEO of CEL SCI Corp $CVM
Ticker: $CVM
Website: https://cel-sci.com/
Geert Kersten Biography
Geert Kersten has served in his current leadership role as Chief Executive Officer at CEL-SCI Corporation (NYSE American: CVM) since 1995 and has been with CEL-SCI since 1987. He has been involved in the pioneering field of cancer immunotherapy for over three decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry. Mr. Kersten also provides CEL-SCI with significant expertise in the fields of finance and law and has a unique vision of how CEL-SCI's Multikine product could potentially change the way cancer is treated. Prior to joining CEL-SCI, Mr. Kersten worked at the law firm of Finley & Kumble and worked at Source Capital. Mr. Kersten received his Undergraduate Degree in Accounting and an M.B.A. from George Washington University, and a law degree (J.D.) from American University in Washington, DC.
Investors Can Learn More:
https://cel-sci.com/new-investor-information/
--- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support185 episodes
Partager
